C07D 311/54
Substituted in the carbocyclic ring
Official title: substituted in the carbocyclic ring
C07D311/54 (Substituted in the carbocyclic ring) appears on 41 US grants and 23 published applications in this corpus.
Search patents in C07D- Granted patents
- 41
- Published applications
- 23
- Assignees
- 36
- Inventors
- 117
- Latest grant
- 21 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 2 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 3 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 3 |
| 2020 | 2 | 2 |
| 2021 | 1 | 0 |
| 2022 | 3 | 4 |
| 2023 | 3 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PTPRD inhibitors and uses thereof21 May 2024US 11,987,564 B2Arizona Board of Regents on Behalf of the University of Arizona
- Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis21 Nov 2023US 11,819,492 B2Centre Hospitalier Universitaire De Poitiers
- Compounds and compositions for treating conditions associated with NLRP activity19 Sep 2023US 11,760,735 B2Novartis AG
- Compounds and compositions for treating conditions associated with NLRP activity7 Mar 2023US 11,597,706 B2Novartis AG
- Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods30 Aug 2022US 11,427,536 B2The Regents of the University of Colorado, a body corporate
- Inhibitors of bromodomain-containing protein 4 and phosphoinositide 3-kinase12 Mar 2026US 2026/0069599 A1Board of Regents of the University of Nebraska
- Compounds and compositions for treating conditions associated with nlrp activity30 Mar 2023US 2023/0099258 A1Novartis AG
- Active heterogenized palladium-bridged-nhc catalysts for carbonylative sonogashira coupling reactions29 Dec 2022US 2022/0411451 A1King Fahd University of Petroleum and Minerals
- Ptprd inhibitors and uses thereof1 Dec 2022US 2022/0380332 A1Arizona Board of Regents on Behalf of the University of Arizona
- Compounds for inhibition of alpha 4 beta 7 integrin19 May 2022US 2022/0152014 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Derivatives of 6,8-difluoro-7-hydroxycoumarin122US 5,830,912 AMolecular Probes, Inc. · 1998
- 4H-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient43US 4,954,518 AToyama Chemical Co., Ltd. · 1990
- Chromone fungicides14US 6,034,121 AAgrevo UK Limited · 2000
- Coumarin derivatives for the treatment of allergies13US 3,974,289 ABeecham Group Limited · 1976
- Antigen, antiserum and immunoassay for theophylline12US 4,302,438 AByk Gulden Lomberg Chemische Fabrik GmbH · 1981